KARLY KINCAID MOSS: Open Payments
NPI 1366781213 · DULUTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,020 in 54 payments from 11 companies in 2025. Trend: 2023 $868 · 2024 $1,164 · 2025 $1,020
Food & beverage: $1,013Education: $7
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $242 |
| Regeneron Healthcare Solutions, Inc. | 10 | $208 |
| ABBVIE INC. | 17 | $194 |
| Galderma Laboratories, L.P. | 5 | $84 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| PFIZER INC. | 3 | $55 |
| LEO Pharma Inc. | 2 | $47 |
| Organon LLC | 2 | $44 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $35 |
| Incyte Corporation | 1 | $25 |
Products named: DUPIXENT, SKYRIZI, NEMLUVIO, RINVOQ, CIBINQO, Rhapsido, ADBRY, VTAMA.
Industry payments across GA — which companies pay providers there.
